Charles E. Welander - Concepedia

Author

Charles E. Welander

Wake Forest University

Also Known As

C E Welander, CHARLES WELANDER, Charles E. Welander, Charles Welander, CharlesE. Welander

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Wake Forest University Atrium Health Wake Forest Baptist Gynecologic Oncology Group

About

Charles E. Welander is an author at Wake Forest University specializing in medicine, oncology, and obstetrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	19	844
2	Cell Biology	3	3	171
3	Public Health	2	2	63
4	Health Sciences	1	1	19
5	Anesthesia	1	1	19

Charles E. Welander

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Four ovarian cancers diagnosed during laparoscopic management of 1011 women with adnexal masses Farr Nezhat, Camran Nezhat, Charles E. Welander, American Journal of Obstetrics and Gynecology Surgical OncologyGynecological SurgeryOvarian CancersMedicineGynecology	1992	207
Combined recombinant human interferon alpha<sub>2</sub> and cytotoxic agents studied in a clonogenic assay Charles E. Welander, Timothy M. Morgan, Howard D. Homesley, International Journal of Cancer	1985	133
Laparoscopic Radical Hysterectomy and Laparoscopically Assisted Vaginal Radical Hysterectomy with Pelvic and Paraaortic Node Dissection Camran Nezhat, Farr Nezhat, Matthew O. Burrell, Journal of Gynecologic Surgery LaparoscopyGynecologic SurgeryPuerto RicoMinimally Invasive ProcedurePelvic Prolapse	1993	123
Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors Kim R. Geisinger, Timothy E. Kute, Mark J. Pettenati, Cancer Steroid MetabolismRadiation OncologyProgesterone ReceptorsHormonal ReceptorSex Steroid Receptors	1989	102
Direct and indirect effects of human recombinant gamma-interferon on tumor cells in a clonogenic assay. Toshiaki Saito, Michael E. Berens, Charles E. Welander PubMed ImmunologyTumor CellsImmunotherapyCancer BiologyTumor Biology	1986	58
A phase I–II trial of intraperitoneal cisplatin and α-lnterferon in patients with persistent epithelial ovarian cancer Jonathan S. Berek, Charles E. Welander, Julian C. Schink, Gynecologic Oncology MedicineIntraperitoneal CisplatinGynecologyCancer TreatmentOncology	1990	50
Pretreatment laparotomy in carcinoma of the cervix Charles E. Welander, Virginia K. Pierce, Dattatreyudu Nori, Gynecologic Oncology Gynecologic SurgeryLaparoscopySurgical OncologyCervical CancerGynecological Surgery	1981	44
Intralesional interferon alfa-2b for the treatment of genital warts Charles E. Welander, Howard D. Homesley, Kenneth A. Smiles, American Journal of Obstetrics and Gynecology PathogenesisAntiviral TherapyGynecologyVirologyTreatment Option	1990	40
A Phase II Study of the Efficacy of Recombinant Interferon Gamma in Relapsing Ovarian Adenocarcinoma Charles E. Welander, Howard D. Homesley, Steven D. Reich, American Journal of Clinical Oncology	1988	37
The effects of estrogen, progesterone, and tamoxifen alone and in combination with cytotoxic agents against human ovarian carcinomain vitro Kim R. Geisinger, Michael E. Berens, Yvonne Duckett, Cancer Hormonal ContraceptiveCytotoxic AgentsOncologyEndocrine-related CancerMedicine	1990	33

Page 1